Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

WuXi AppTec Opens China’s First GMP Biologics Facility

publication date: Oct 16, 2012
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
WuXi AppTech has officially opened its GMP manufacturing facility for biologic drugs – the first such facility in China compliant with GMP standards in China, the US and Europe. WuXi has constructed a facility that is state-of-the-art, including the first operation anywhere in the globe that uses 100% disposable equipment for producing biologics drug substances. To mark the milestone, WuXi hosted a Global Monoclonal Antibody Summit in WuXi last week, which was attended by more than 300 people. More details....

Stock Symbol: (NYSE: WX)

Share this with colleagues:  


This article is available for purchase - please click here for details.


Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Event Updates
Greg Scott will be attending and speaking at these events:
 
 
 
Hope to see you there!
 
ChinaBio® Events
More events coming soon...

>> More events...

Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Sponsors